Meropenem-vaborbactam restoration of first-line drug efficacy and comparison of meropenem-vaborbactam-moxifloxacin versus BPaL MDR-TB regimen.
Singh, Sanjay⋅Gumbo, Tawanda⋅Alffenaar, Jan-Willem⋅Boorgula, Gunavanthi D⋅Shankar, Prem⋅Thomas, Tania A⋅Dheda, Keertan⋅Malinga, Lesibana⋅Raj, Prithvi⋅Aryal, Santosh and Srivastava, Shashikant
International journal of antimicrobial agents, vol. 62, (no. 6), pp. 106968, September 17, 2023. | Journal Article